Vulvovaginal Pyoderma Gangrenosum in a Patient Treated With Ocrelizumab for Multiple Sclerosis

Breneman, A. N., Eber, A. E., Haque, H., Levine, L., Askanase, A., Riley, C. S., Pomeranz, M. K., Hassan, D., Mancebo, S. E., Polin, M., Melamed, A., Bordone, L. A., Rosser, M., Gockley, A., & Gallitano, S. M. (2022). Vulvovaginal Pyoderma Gangrenosum in a Patient Treated With Ocrelizumab for Multiple Sclerosis. Journal of Lower Genital Tract Disease, 26(2), 189–191. https://doi.org/10.1097/lgt.0000000000000661
Authors:
Alyssa N. Breneman
Ariel E. Eber
Hoosna Haque
Libby Levine
Anca Askanase
Claire S. Riley
Miriam Keltz Pomeranz
Dahlia Hassan
Silvia E. Mancebo
Melanie Polin
Alexander Melamed
Lindsey A. Bordone
Mary Rosser
Allison Gockley
Stephanie M. Gallitano
Affiliated Authors:
Alyssa N. Breneman
Ariel E. Eber
Hoosna Haque
Libby Levine
Anca Askanase
Claire S. Riley
Dahlia Hassan
Melanie Polin
Alexander Melamed
Lindsey A. Bordone
Mary Rosser
Allison Gockley
Stephanie M. Gallitano
Subjects:
Author Keywords:
pyoderma gangrenosum
vulvovaginal
rituximab
ocrelizumab
intravenous immunoglobulin
side effect
Publication Type:
Article
Unique ID:
10.1097/LGT.0000000000000661
PMID:
Publication Date:
Data Source:
Scopus

Record Created: